Van Tuyl Christopher

Track

Insider profile

Performance

Overall performance
1.8
Performance over holding periods
1.8
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 21% 68% 82%
Transactions
8 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Van Tuyl Christopher's trades of Immunovant Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-10 2026-07-08
S Sale
8,690 -43.5%
424.29
US$1,338,101 		8,690 -43.5% 424.29 US$1,338,101
2026-07-10 2026-07-08
S Sale
62,230 +33.1%
294.74
US$1,776,493 		62,230 +33.1% 294.74 US$1,776,493
2026-06-26 2026-06-26
S Sale
3,872 +30.7%
393.99
US$831,264 		3,872 +30.7% 393.99 US$831,264
2026-06-26 2026-06-26
S Sale
14,982 -7.6%
38.19
US$572,163 		14,982 -7.6% 38.19 US$572,163
2026-06-26 2026-06-26
PrS Proposed sale
17,824
38.31
US$682,800 		17,824 38.31 US$682,800
2026-06-22 2026-06-18
S Sale
2,634 -1.4%
35.39
US$93,217 		2,634 -1.4% 35.39 US$93,217
2026-06-22 2026-06-18
S Sale
2,634 -1.4%
35.39
US$93,217 		2,634 -1.4% 35.39 US$93,217
2026-04-10 2026-04-08
S Sale
5,165 -2.7%
24.83
US$128,247 		5,165 -2.7% 24.83 US$128,247
2026-03-20 2026-03-18
S Sale
2,877 -1.9%
24.97
US$71,839 		2,877 -1.9% 24.97 US$71,839
2025-12-19 2025-12-18
S Sale
2,284 -1.5%
27.38
US$62,536 		2,284 -1.5% 27.38 US$62,536
2025-12-19 2025-12-18
S Sale
8,529 -5.3%
26.78
US$228,407 		8,529 -5.3% 26.78 US$228,407